Nutrien (NYSE:NTR) Rating Increased to Overweight at Piper Sandler

Piper Sandler upgraded shares of Nutrien (NYSE:NTRFree Report) from an underweight rating to an overweight rating in a research report sent to investors on Monday morning, MarketBeat.com reports. Piper Sandler currently has $58.00 price objective on the stock, up from their prior price objective of $50.00.

Other equities analysts have also recently issued reports about the company. Oppenheimer started coverage on Nutrien in a report on Thursday, December 12th. They issued an “outperform” rating and a $60.00 target price on the stock. TD Securities decreased their price objective on Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a research note on Tuesday, November 12th. Raymond James raised Nutrien from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $58.00 to $60.00 in a research report on Tuesday, December 3rd. JPMorgan Chase & Co. raised shares of Nutrien from an “underweight” rating to a “neutral” rating and increased their target price for the stock from $40.00 to $50.00 in a report on Monday. Finally, Royal Bank of Canada restated an “outperform” rating and set a $60.00 target price on shares of Nutrien in a research note on Friday, September 20th. One research analyst has rated the stock with a sell rating, five have given a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, Nutrien has an average rating of “Moderate Buy” and an average target price of $59.21.

Read Our Latest Report on Nutrien

Nutrien Price Performance

NYSE NTR opened at $52.08 on Monday. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $25.64 billion, a P/E ratio of 34.95, a PEG ratio of 1.11 and a beta of 0.81. The company has a 50-day moving average price of $46.90 and a 200-day moving average price of $47.85. Nutrien has a 52 week low of $43.69 and a 52 week high of $60.87.

Nutrien (NYSE:NTRGet Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). The business had revenue of $5.35 billion for the quarter, compared to analysts’ expectations of $5.26 billion. Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The firm’s quarterly revenue was down 5.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.35 earnings per share. Equities research analysts anticipate that Nutrien will post 3.5 earnings per share for the current year.

Nutrien Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 17th. Shareholders of record on Tuesday, December 31st will be paid a $0.939 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.76 annualized dividend and a yield of 7.21%. This is a boost from Nutrien’s previous quarterly dividend of $0.54. Nutrien’s payout ratio is presently 144.97%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in NTR. Empirical Asset Management LLC bought a new position in Nutrien during the fourth quarter valued at approximately $1,724,000. Gateway Investment Advisers LLC raised its holdings in shares of Nutrien by 344.5% during the 4th quarter. Gateway Investment Advisers LLC now owns 38,043 shares of the company’s stock worth $1,702,000 after acquiring an additional 29,484 shares in the last quarter. Dixon Mitchell Investment Counsel Inc. boosted its position in shares of Nutrien by 2.2% during the 4th quarter. Dixon Mitchell Investment Counsel Inc. now owns 189,725 shares of the company’s stock valued at $8,485,000 after acquiring an additional 4,157 shares during the last quarter. Foundation Resource Management Inc. purchased a new position in shares of Nutrien in the fourth quarter valued at $7,744,000. Finally, Covea Finance increased its position in Nutrien by 21.9% in the fourth quarter. Covea Finance now owns 55,600 shares of the company’s stock worth $2,485,000 after purchasing an additional 10,000 shares during the last quarter. Hedge funds and other institutional investors own 63.10% of the company’s stock.

About Nutrien

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Articles

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.